Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Has Consensus Target Price of $493.54

Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned an average rating of “Moderate Buy” from the thirty analysts that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, twenty-three have given a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $493.54.

Several research firms have weighed in on ISRG. HSBC cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective on the stock. in a research report on Thursday, July 30th. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Robert W. Baird increased their target price on Intuitive Surgical from $513.00 to $550.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a research note on Wednesday, October 21st. Finally, Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares in the company, valued at approximately $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 39,056 shares of company stock valued at $17,585,864 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently bought and sold shares of the business. Private Advisor Group LLC grew its stake in shares of Intuitive Surgical by 26.4% in the third quarter. Private Advisor Group LLC now owns 35,645 shares of the medical equipment provider’s stock worth $14,494,000 after acquiring an additional 7,448 shares during the last quarter. Ieq Capital LLC raised its position in shares of Intuitive Surgical by 88.6% in the 3rd quarter. Ieq Capital LLC now owns 67,200 shares of the medical equipment provider’s stock worth $27,326,000 after purchasing an additional 31,566 shares during the last quarter. Focus Advisor Solutions LLC raised its position in shares of Intuitive Surgical by 166.1% in the 3rd quarter. Focus Advisor Solutions LLC now owns 9,626 shares of the medical equipment provider’s stock worth $3,915,000 after purchasing an additional 6,009 shares during the last quarter. Checchi Capital Advisers LLC raised its position in shares of Intuitive Surgical by 5.1% in the 3rd quarter. Checchi Capital Advisers LLC now owns 2,583 shares of the medical equipment provider’s stock worth $1,050,000 after purchasing an additional 125 shares during the last quarter. Finally, Independent Advisor Alliance boosted its stake in Intuitive Surgical by 14.6% in the 3rd quarter. Independent Advisor Alliance now owns 5,652 shares of the medical equipment provider’s stock worth $2,459,000 after purchasing an additional 720 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 2.3%

Shares of ISRG opened at $450.04 on Friday. The firm’s 50-day moving average price is $413.15 and its 200-day moving average price is $431.20. The firm has a market capitalization of $156.00 billion, a price-to-earnings ratio of 51.63, a PEG ratio of 3.17 and a beta of 1.45. Intuitive Surgical has a 1-year low of $328.57 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the previous year, the company earned $2.40 earnings per share. Intuitive Surgical’s quarterly revenue was up 21.7% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical will post 9.37 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.